Related Experiment Video
Updated: Jul 11, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Implementing rotavirus vaccination in Asia
Mathuram Santosham1, E Anthony S Nelson, Joseph S Bresee
1Department of International Health, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe Street, E8132, 621 N. Washington Street, Baltimore, MD 21205, USA. msantosh@jhsph.edu
Insights
Rotavirus vaccines are recommended for national immunization programs in Asia. Further data on disease burden and economic impact are needed for widespread implementation to reduce childhood illness.
Area of Science:
- Pediatrics
- Vaccinology
- Public Health
Background:
- Rotavirus is a significant cause of childhood morbidity and mortality in Asia.
- The Asian Pacific Pediatric Association (APPA) and international experts convened to discuss rotavirus vaccine implementation.
- Existing rotavirus vaccines are safe, well-tolerated, and efficacious, with more candidates in development.
Purpose of the Study:
- To summarize recommendations for rotavirus vaccine integration into National Immunization Programmes (NIP) in Asian countries.
- To highlight the need for additional disease burden and economic evaluation data for policy decisions.
- To address implementation considerations, including co-administration with other vaccines.
Main Methods:
- Expert consensus and discussion during the 2006 APPA meeting.
- Review of existing rotavirus vaccine data (safety, efficacy).
- Consideration of disease burden and economic evaluation requirements.
Main Results:
- Strong recommendation for rotavirus vaccine use in Asian NIPs.
- Agreement on the necessity of further disease burden data and economic evaluations for nationwide implementation.
- Discussion of practical aspects like concomitant vaccine use.
Conclusions:
- Rotavirus vaccines offer substantial potential to decrease rotavirus disease burden in Asian children.
- Policy decisions on vaccine introduction require robust data and economic assessments.
- Strategic implementation planning is crucial for maximizing vaccine impact on child health in Asia.
Abstract:
At the 2006 meeting of the Asian Pacific Pediatric Association (APPA), the Asia Pacific regional rotavirus community and international experts strongly recommended that rotavirus vaccines be used in National Immunization Programmes (NIP) in countries in Asia. Two rotavirus vaccine candidates are currently licensed and have been demonstrated to be safe, well tolerated and highly efficacious. Several additional vaccines are in the late stages of development. The conference participants agreed that decisions on the introduction of rotavirus vaccines may require additional disease burden data in some countries and that economic evaluations will help policymakers reach decisions on nationwide rotavirus vaccine implementation. Other potential issues that arise with vaccine implementation, for example, the concomitant use of rotavirus vaccines with other vaccines, were also discussed. Rotavirus vaccines have the potential to substantially reduce morbidity and mortality from rotavirus disease and impact children's health in Asia.
Related Concept Videos
Poliomyelitis
Vaccinations
Respiratory Syncytial Virus Disease
Vaccine Production
Bacterial Gastroenteritis
